tiprankstipranks
Trending News
More News >
SciDev Ltd (AU:SDV)
ASX:SDV

SciDev Ltd (SDV) AI Stock Analysis

Compare
6 Followers

Top Page

AU

SciDev Ltd

(Sydney:SDV)

Rating:59Neutral
Price Target:
AU$0.50
▲(56.25%Upside)
SciDev Ltd's overall stock score is moderately low due to bearish technical indicators, with the stock trading below key moving averages and negative MACD. The financial performance is strong, with robust revenue growth and improved profitability, but the valuation is high, with a P/E ratio above the industry average without a dividend yield to compensate. The lack of recent earnings call insights and corporate events further limits positive influences on the stock score.

SciDev Ltd (SDV) vs. iShares MSCI Australia ETF (EWA)

SciDev Ltd Business Overview & Revenue Model

Company DescriptionSciDev Ltd (SDV) is an Australian-based company operating in the environmental services and water treatment sectors. The company specializes in the development and supply of chemicals and technology solutions aimed at enhancing the efficiency of industrial processes while minimizing environmental impact. SciDev's core products include coagulants, flocculants, and other water treatment chemicals, which are essential in industries such as mining, oil and gas, and infrastructure.
How the Company Makes MoneySciDev Ltd generates revenue through the sale of its chemical products and technology solutions to various industrial sectors. The company's key revenue streams include contracts and agreements with mining companies, oil and gas operators, and infrastructure projects that require effective water and waste management solutions. Additionally, SciDev's earnings are supported by its partnerships with global chemical manufacturers and distributors, allowing it to expand its market reach and enhance its service offerings. By providing tailored solutions that improve operational efficiency and environmental compliance, SciDev secures long-term relationships with its clients, contributing to its financial performance.

SciDev Ltd Financial Statement Overview

Summary
SciDev Ltd displays a strong financial position with robust revenue growth and improved profitability margins. The company maintains a healthy balance sheet with low leverage, creating a stable financial foundation. Cash flows have improved, indicating better cash management practices. Overall, SciDev Ltd is progressing positively with sound financial health.
Income Statement
82
Very Positive
SciDev Ltd has shown strong revenue growth, with a significant increase in Total Revenue from the previous year. The Gross Profit Margin and Net Profit Margin have improved, indicating better cost management and profitability. The EBIT and EBITDA margins have also shown positive trends, further solidifying the company's operational efficiency.
Balance Sheet
76
Positive
The balance sheet is stable with a healthy Equity Ratio indicating a strong asset base relative to liabilities. The Debt-to-Equity Ratio is low, reflecting low leverage and financial risk. Return on Equity (ROE) has turned positive, showcasing improved earnings for shareholders.
Cash Flow
74
Positive
The cash flow statement reflects a solid Operating Cash Flow to Net Income Ratio, demonstrating effective cash generation from operations. Free Cash Flow has improved, showing a positive growth rate, though it's still important to monitor capital expenditures and investing activities.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
108.91M109.09M89.72M55.60M42.52M17.91M
Gross Profit
34.90M33.97M6.83M3.69M1.37M-476.31K
EBIT
12.38M4.62M456.00K-479.00K-513.47K-2.89M
EBITDA
7.77M7.65M3.92M1.13M1.88M-1.86M
Net Income Common Stockholders
2.05M2.17M-339.00K-616.00K3.45M-875.24K
Balance SheetCash, Cash Equivalents and Short-Term Investments
3.08M9.43M7.73M14.06M7.01M4.48M
Total Assets
13.84M72.01M67.37M71.16M56.15M27.17M
Total Debt
88.45K5.13M3.48M2.90M5.13M538.35K
Net Debt
-2.99M-4.30M-4.25M-11.17M-1.88M-3.94M
Total Liabilities
4.13M21.78M19.35M22.32M24.54M9.76M
Stockholders Equity
9.72M50.24M48.02M48.84M31.61M17.41M
Cash FlowFree Cash Flow
6.91M4.48M522.00K-3.83M-1.92M-1.05M
Operating Cash Flow
8.21M6.48M4.81M-1.31M-1.32M-177.47K
Investing Cash Flow
-5.02M-3.71M-8.39M-6.65M-2.49M-1.79M
Financing Cash Flow
1.43M-1.06M-2.83M14.99M6.34M4.70M

SciDev Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.32
Price Trends
50DMA
0.38
Negative
100DMA
0.43
Negative
200DMA
0.49
Negative
Market Momentum
MACD
-0.02
Positive
RSI
29.14
Positive
STOCH
4.17
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SDV, the sentiment is Negative. The current price of 0.32 is below the 20-day moving average (MA) of 0.35, below the 50-day MA of 0.38, and below the 200-day MA of 0.49, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 29.14 is Positive, neither overbought nor oversold. The STOCH value of 4.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SDV.

SciDev Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AURUL
73
Outperform
AU$669.72M108.1411.59%9.76%-28.92%
AUMAH
72
Outperform
AU$619.54M13.357.28%3.73%19.01%-34.62%
AULYC
60
Neutral
AU$8.77B158.092.27%-20.07%-74.91%
AUSDV
59
Neutral
AU$59.88M29.174.12%20.25%
AUAJL
53
Neutral
AU$8.25M
3.26%-800.00%
51
Neutral
$2.04B-1.15-21.24%3.95%2.91%-30.44%
AUMSB
48
Neutral
$2.38B-21.31%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:SDV
SciDev Ltd
0.30
-0.08
-21.05%
AU:MAH
Macmahon Holdings Limited
0.30
0.02
7.66%
AU:LYC
Lynas Rare Earths
8.60
2.06
31.50%
AU:AJL
AJ Lucas Group
0.01
>-0.01
-9.09%
AU:MSB
Mesoblast Limited
1.80
0.73
68.22%
AU:RUL
RPMGlobal Holdings Ltd
3.19
0.54
20.38%

SciDev Ltd Corporate Events

SciDev Reports Strong Q3 FY25 Amid Market Volatility
May 7, 2025

SciDev Limited reported a solid Q3 FY25 performance, with a 10% increase in revenue to $26.3 million and a 200% rise in EBITDA to $2.1 million, despite volatile market conditions. The company expanded its market share in the US Oil & Gas sector and secured significant contracts, including a PFAS remediation project for the US Department of Defence. While client-driven delays may shift some revenues to FY26, the demand for SciDev’s proprietary chemistry remains strong, supporting improved margins. The company is well-positioned to capitalize on the growing demand for sustainable water treatment solutions, with a healthy business development pipeline across all units.

SciDev Announces Strategic Board Restructuring
Mar 31, 2025

SciDev Ltd has announced significant changes to its board composition, with Mike Utsler appointed as the new Chairman, effective April 1, 2025. This change is part of a strategic move to guide the company through its next growth phase. Additionally, CEO Sean Halpin will transition to the role of Managing Director, following the resolution of conflicts of interest related to a previous acquisition. The board also welcomes Johannes Risseeuw as a Non-Executive Director, replacing Jon Gourlay, who will retire later in the year. These changes are expected to strengthen SciDev’s leadership and support its long-term growth objectives.

SciDev Secures First US Contract for PFAS Remediation with DoD
Mar 26, 2025

SciDev Ltd has secured its first contract in the United States for PFAS remediation, partnering with consulting firm Halff to treat PFAS-contaminated water at US Department of Defense sites. This A$396K contract involves treating up to 190,000 liters of contaminated water across four installations in the Southern US, marking a significant milestone in SciDev’s expansion into the US water technology market. The contract opens up a substantial market opportunity for SciDev, as the US PFAS remediation market is valued at USD $220 billion, with 55,000 identified sites requiring treatment. This development underscores the critical role of SciDev’s proprietary solutions in addressing environmental challenges and highlights the growing global demand for sustainable water treatment solutions.

SciDev Ltd Issues Performance Rights to Boost Employee Engagement
Mar 25, 2025

SciDev Ltd has announced the issuance of 2,732,919 FY2025 Performance Rights as part of an employee incentive scheme. This move is expected to enhance employee engagement and align their interests with the company’s growth objectives, potentially strengthening SciDev’s position in the competitive technology industry.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.